TrialThe Lancet. Oncology2020

Cabozantinib in patients with advanced Ewing sarcoma or osteosarcoma (CABONE): a multicentre, single-arm, phase 2 trial.

Antoine Italiano et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.